Veristat Launches AI Biostatistics Platform, Cutting Clinical Trial Data Readout Time from 5 Weeks to 5 Days* Without Regulatory Risks

Contributed by: Business Wire

Logo

Tags

Other Health

Research

General Health

Pharmaceutical

Technology

Artificial Intelligence

Health Technology

Clinical Trials

Science

Biotechnology

Other Science

Health

InStat

More Like This

Veristat Acquires Biometrics-focused Instat Clinical Research

Veristat Joins the Alliance for Regenerative Medicine (ARM) to Help Address Critical Issues Impacting the Advanced Therapy Sector

Veristat to Acquire Certara’s Regulatory and Medical Writing Business

Rachel Page, Chief Commercial Officer, Veristat (Photo: Business Wire)

Veristat Appoints New Chief Commercial Officer

inThought and inThought Labs Announce AI Initiative: Cut Down Tedious Tasks

Instem Announces Provantis® 12: A Powerful Step Forward in Preclinical Study Management

Scientist.com Adds Trial Insights™ to Clinical Labs Navigator™ Solution, Giving Researchers Instant Access to Global Clinical-Trial Intelligence

Instem Taps ex-Novartis Head of Emerging Technologies to Put Science Behind Practical AI and NAMs